Xiang Y - Search Results

1

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway.

Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang X, Zhu J, Zhao C. Yang L, et al. Among authors: xiang y. Cancer Manag Res. 2019 Feb 1;11:1167-1176. doi: 10.2147/CMAR.S171517. eCollection 2019. Cancer Manag Res. 2019. PMID: 30774444 Free PMC article.

2

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway.

Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C. Bai E, et al. Among authors: xiang y. Cancer Manag Res. 2018 Mar 23;10:565-581. doi: 10.2147/CMAR.S159090. eCollection 2018. Cancer Manag Res. 2018. PMID: 29606890 Free PMC article.

3

Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.

Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, Zhao C. Zheng H, et al. Among authors: xiang y. Mol Carcinog. 2019 Apr;58(4):565-576. doi: 10.1002/mc.22951. Epub 2019 Jan 4. Mol Carcinog. 2019. PMID: 30520143

4

Osthole inhibits triple negative breast cancer cells by suppressing STAT3.

Dai X, Yin C, Zhang Y, Guo G, Zhao C, Wang O, Xiang Y, Zhang X, Liang G. Dai X, et al. Among authors: xiang y. J Exp Clin Cancer Res. 2018 Dec 22;37(1):322. doi: 10.1186/s13046-018-0992-z. J Exp Clin Cancer Res. 2018. PMID: 30577812 Free PMC article.

5

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.

Yang L, Lin S, Kang Y, Xiang Y, Xu L, Li J, Dai X, Liang G, Huang X, Zhao C. Yang L, et al. Among authors: xiang y. J Exp Clin Cancer Res. 2019 Jan 23;38(1):31. doi: 10.1186/s13046-018-1015-9. J Exp Clin Cancer Res. 2019. PMID: 30674340 Free PMC article.

6

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.

Lin S, Yang L, Yao Y, Xu L, Xiang Y, Zhao H, Wang L, Zuo Z, Huang X, Zhao C. Lin S, et al. Among authors: xiang y. J Exp Clin Cancer Res. 2019 Jul 8;38(1):293. doi: 10.1186/s13046-019-1303-z. J Exp Clin Cancer Res. 2019. PMID: 31287013 Free PMC article.

7

Design, Synthesis, And Evaluation Of Cyanopyridines As Anti-Colorectal Cancer Agents Via Inhibiting STAT3 Pathway.

Xu L, Shi L, Qiu S, Chen S, Lin M, Xiang Y, Zhao C, Zhu J, Shen L, Zuo Z. Xu L, et al. Among authors: xiang y. Drug Des Devel Ther. 2019 Sep 24;13:3369-3381. doi: 10.2147/DDDT.S217800. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31576111 Free PMC article.

8

Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells.

Zhao C, Yang L, Zhou F, Yu Y, Du X, Xiang Y, Li C, Huang X, Xie C, Liu Z, Lin J, Wang L, Liang G, Cui R. Zhao C, et al. Among authors: xiang y. Oncogene. 2020 May;39(20):3997-4013. doi: 10.1038/s41388-020-1271-y. Epub 2020 Apr 2. Oncogene. 2020. PMID: 32242147

9

Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway.

Yang L, Yao Y, Bai Y, Zheng D, Zhou F, Chen L, Hu W, Xiang Y, Zhao H, Liu Z, Wang L, Huang X, Zhao C. Yang L, et al. Among authors: xiang y. Phytomedicine. 2021 Jan;80:153366. doi: 10.1016/j.phymed.2020.153366. Epub 2020 Oct 3. Phytomedicine. 2021. PMID: 33080566

10

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.

Yang L, Zhou F, Zhuang Y, Liu Y, Xu L, Zhao H, Xiang Y, Dai X, Liu Z, Huang X, Wang L, Zhao C. Yang L, et al. Among authors: xiang y. Br J Cancer. 2021 Feb;124(3):645-657. doi: 10.1038/s41416-020-01135-6. Epub 2020 Oct 30. Br J Cancer. 2021. PMID: 33122847 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,053 results

Search Page

Filters